«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:

2011年第4期

页码:

468

栏目:

临床研究

出版日期:

2011-08-25

文章信息/Info

Title:

Effects of pentoxifylline on immune modulatory mechanism of CD+4Th cells and soluble Fas in patients with congestive heart failure

作者:

蔡伦安¹; 3; 卢永昕¹; 周晗²; 苏冠华¹

1.华中科技大学同济医学院协和医院心内科，湖北 武汉 430022；2.河南省人民医院心内科，河南 郑州 450003；3.河南省信阳市中心医院心内科，河南 信阳 464000

Author(s):

CAI Lun-an;  LU Yong-xin;  ZHOU Han;  SU Guan-hua

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China

关键词:

己酮可可碱; 慢性心力衰竭; Th1淋巴细胞; Th2淋巴细胞; 凋亡抑制因子; 免疫调节

Keywords:

pentoxifylline;  heart failure;  Th1-lymphocytes;  Th2-lymphocytes;  immunomodulation

分类号:

R541.6

DOI:

61-1268/R.20110503.1516.012

文献标识码:

A

摘要:

目的:探讨己酮可可碱(Pentoxifylline,PTX)对慢性心力衰竭(CHF)患者外周血辅助性T淋巴细胞(Th)免疫调节及血浆细胞凋亡抑制因子（Fas/Apo-1）水平的影响。方法： 采用流式细胞术，检测40例心力衰竭(HF)患者和10例正常对照者外周血CD4+Th1和Th2细胞及其分泌的细胞因子干扰素-γ( IFN-γ)和白介素-10(IL-10)的变化。采用ELISA法测定HF患者治疗前后外周血肿瘤坏死因子-α（TNF-α）、IL-10及Fas/Apo-1水平的变化。采用超声心动图检测HF患者射血分数(EF)的变化。结果： HF患者治疗1个月后，PTX治疗组与常规治疗组相比较，分泌IFN-γ的Th1型细胞所占百分比显著降低(P<0.01)；而分泌IL-10的Th2型细胞所占百分比明显升高(P<0.01)；外周血TNF-α及Fas/Apo-1的水平显著降低(分别为P<0.05和P<0.01)；EF显著提高(P<0.01)。结论： HF患者在常规治疗的基础上应用PTX治疗后，EF得到改善，可能与其对HF患者Th1/Th2细胞比例失衡产生的免疫调节作用，以及通过免疫调节影响炎性细胞因子和凋亡抑制因子的激活与分泌有关。

Abstract:

AIM:To investigate the effects of pentoxifylline (PTX) on the immune modulatory mechanism of CD4+Th and soluble Fas in patients with chronic heart failure (CHF). METHODS: Cytokine-producing Th lymphocytes were quantified by 3-color flow cytometry in 40 CHF patients. Concentrations of TNF-α, IL-10 and Fas/Apo-1 were examined by ELISA, and the ejection fraction was measured by ultrasound echocardiography. RESULTS: The frequencies of IFN-γ-producing Th1 cells were significantly lower and the frequency of IL-10-producing Th2 cells was higher (P<0.01). Levels of TNF-α and Fas/Apo-1 were lower (P<0.05, P<0.01) and the ejection fraction was higher in PTX group than those in routine group after 1-month therapy. CONCLUSION: The improvement of ejection fraction resulting from conventional treatment plus pentoxifylline may be related with the effects of pentoxifylline on the immune modulation on Th1/Th2 functional imbalance in CHF patients and on the activation and secretion of inflammatory cytokines and Fas/Apo-1 through immune modulatory mechanisms.

参考文献/References

[1]Mann DL.Inflammatory mediators and the failing heart:past, present, and the foreseeable future[J].Circ Res,2002,91(11):988-998.
[2]Narula J,Haider N,Virmani R,et al.Apoptosis in myocytes in end-stage heart failure[J].N Engl J Med,1996, 335(16):1182-1189.
[3]Sliwa K, Skudicky D,Candy G,et al.Randomized investigation ofeffects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy[J].Lancet,1998,351(9109):1091-1093.
[4]李爱华,卢永昕,罗萍,等.己酮可可碱对NF-κB介导的新生大鼠心肌细胞凋亡的影响[J].山东医药,2006,46(5):20-21.
[5]万建平,卢永昕,徐玉兰,等.Th1型细胞因子干扰素γ及Th2型细胞因子白细胞介素10水平在慢性心力衰竭患者接受己酮可可碱干预过程中的变化:随机对照[J].中国组织工程研究与临床康复,2007,45(11):9079-9082.
[6]Meldrum DR.Tumor necrosis factor in the heart[J].Am J Physiol,1998,274(3 Pt 2):R577-R595.
[7]Filippatos G,Leche C,Sunga R,et al.Expression of FAS adjacent to fibrotic foci in the failing human heart is not associated with increased apoptosis[J].Am J Physiol,1999,277(2 Pt 2):H445-H451.
[8]Song W,Lu X,Feng Q.Tumor necrosis factor alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes［J］. Cardiovasc Res,2000,45(3):595-602.
[9]Schumann H,Morawietz H,Hakim K,et al.Alterative splicing of primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium[J].Biochem Biophys Res Commun,1997,239(3):794-798.
[10]Yamaoka-Tojo M,Tojo T,Inomata T,et al.Circulating levels of interleukin-18 reflect etiologies of heart failure:Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure[J].J Card Fail,2002,8(1):21-27.
[11]徐玉兰,卢永昕,万建平,等.己酮可可碱对慢性心力衰竭患者CD4+Th细胞免疫调节的研究[J].山东医药,2007,24(5):301-303.
[12]Gullestad L,Aass H,Fjeld JG,et al.Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure[J].Circulation,2001,103(2):220-225.
[13]Staudt A,Schaper F,Stangl V,et al.Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution[J].Circulation,2001,103 (22):2681-2686.
[14]Cooper LT,Belohlavek M,Korinek J,et al.A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy[J].J Clin Apher,2007,22(4):210-214.
[15]Bolton AE.Biologic effects and basic science of a novel immune-modulation therapy[J].Am J Cardiol,2005,95(11A):24C-29C.
[16]Gage JR,Fonarow G, Hamilton M,et al.Beta blocker and angiotens in-converting enzyme inhibitor therapy is as sociated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure[J].Neuroimmunomodulation,2004,11(3):173-180.
[17]Cheng X,Ding Y, Xia C,et al. Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure[J].J Card Fail, 2009,15(2):158-162.
[18]Samardzic T, Jankovic V, Stosic-Grujicic S, et al. Pentoxifylline inhibits the synthesis and IFN-γ-inducing activity of IL-18[J].Clin Exp Immunol,2001,124(2):274-281.
[19]Lazarczyk M,Grezla T,Niderla J,et al.Influence of pentoxifylline on erforin expression in human PBMC[J].Int J Mol Med,2004,14(4):725-728.
[20]Doherty GM,Jensen JC,Alexander HR,et al.Pentoxifylline suppression of tumor necrosis factor gene transcription[J].Surgery,1991,110(2):192-198.
[21]罗萍,卢永昕,李爱华,等.己酮可可碱对体外内毒素诱导大鼠心肌细胞生成TNF-α的影响[J].山东医药, 2005, 45(35):1-2.
[22]Sliwa K, Woodiwiss A, Kone VN,et al.Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study[J].Circulation, 2004,109(6):750-755.
[23]Belloc F,Jaloustre C,Dumain P,et al.Effect of pentoxifylline on apoptosis of cultured cells[J].J Cardiovasc Pharmacol,1995,25(Suppl 2):S71-S74.

备注/Memo

备注/Memo:

收稿日期：2010-09-26.作者简介：蔡伦安，副主任医师,博士Email:tsaiyifee@ yahoo.com.cn

常用功能

更新日期/Last Update: 2011-06-02